- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07288684
Chiropractor Delivered Virtual Intervention After Vertebral frActure (VIVA)
Chiropractor Delivered Virtual Intervention After Vertebral frActure (VIVA)
This study will determine feasibility of a chiropractor delivered virtual intervention for individuals following osteoporotic vertebral fracture.
This pilot trial will have two parallel groups with a 1:1 ratio. Participants will be randomized to: 1) immediate receipt; or 2) waitlist usual care control and delayed receipt of VIVA 10 weeks post-randomization.
VIVA is an intervention for people with vertebral fractures that covers four areas: pain management, safe movement, exercise, and nutrition. It includes print and video resources, and a framework for goal setting, selecting exercises, and teaching body mechanics.
A chiropractor (DC) completes a virtual assessment and then leads twelve 1:1 virtual sessions (via Zoom) over eight weeks. Sessions start with brief education on a topic (e.g., safe movement, pain management, exercise, nutrition), followed by training and modeling of exercise and safe movement strategies, then goal setting, and action planning.
This trial will be considered feasible if a) we recruit 14 people in eight months; b) 80% of participants complete the trial; and c) exercise adherence is 75%.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Spine fractures are the most common fracture due to osteoporosis. They can happen because of falls or activities of daily life like bending and lifting. Fractures of the spine can result in pain, which can last for a long time. Spine fractures can affect breathing, appetite, digestion, and mobility, and can restrict or modify an individuals' work or daily activities.
There are no standard rehabilitation programs after spine fracture, and patients often must pay out of pocket for rehabilitation. Rehabilitation can be hard to access (especially in rural or remote locations) and it can be difficult to find providers with training and expertise to treat spine fractures.
Our team includes Osteoporosis Canada, patients, health care professionals, and researchers from multiple provinces. We reviewed research, consulted patients and healthcare providers to understand their experiences with spine fracture rehabilitation to develop a Toolkit for a virtual rehabilitation program for people with spine fracture, called VIVA.
VIVA is an intervention for people with vertebral fractures that covers four areas: pain management, safe movement, exercise, and nutrition. It includes print and video resources, and a framework for goal setting, selecting exercises, and teaching body mechanics. We used the Behavior Change Wheel method to select four implementation strategies: education on pain management, safe movement, exercise, and nutrition; modeling of and training on exercises, safe movement, and pain management strategies; and enablement, such as goal setting, action planning, and self-monitoring.
Participants receive a technology consultation 1-2 weeks prior to baseline assessment, and receive intervention in week one (immediately post-randomization) or in week ten (waitlist control). A provider completes a virtual assessment, and then leads 1:1 once-weekly virtual sessions (via Zoom) over eight weeks. Sessions start with brief education on a topic (e.g., safe movement, pain management, exercise, nutrition), followed by training and modeling of exercise and safe movement strategies, then goal setting, and action planning.
The provider prescribes resources (e.g., summaries, pictures, videos) using the Wibbi app (https://wibbi.com/) or that can be emailed or mailed. Exercises are tailored to the participant's abilities, and target balance, muscle strength, and endurance of back extensor muscles and scapular stabilizers. The first session will serve as an intake session.
Depending on the patient needs the provider either will provide training on exercises, movement tips, or pain management tips. Finally, the provider will show how to monitor performance and adherence throughout the intervention, discuss and decide on the area of focus for the next session (i.e., pain management, safe movement, exercise, nutrition), and schedule the next session.
The remaining 11 sessions from Week 2 to Week 8 will start with education on the chosen topic. The provider will review progress on exercises, movement strategies, or pain management tips from the previous sessions and demonstrate new exercises or strategies. The provider will deliver the exercises prescribed and any educational resources through the Wibbi app and decide on an area of focus for the next session based on discussion with the participant.
VIVA was designed and user tested in the context of physiotherapist delivery, but chiropractors may be well-situated to deliver VIVA. Chiropractors and physiotherapists manage similar patient bases with overlapping scopes of practice. We propose a pilot study of the feasibility of the implementation of the VIVA Toolkit with a chiropractor as the provider (i.e., Can we recruit people? Do they like the program? Do they attend?). Through this study we will also collect information about pain, quality of life and physical functioning before and after the intervention. We will then use the findings of this study to determine if it is feasible to include chiropractor providers in a larger clinical trial.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Allison A Legg
- Phone Number: 289-380-0859
- Email: a2legg@uwaterloo.ca
Study Contact Backup
- Name: Lora Giangregorio, PhD
- Email: lora.giangregorio@uwaterloo.ca
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L3G1
- Recruiting
- University of Waterloo
-
Contact:
- Lora Giangregorio, PhD
- Email: lora.giangregorio@uwaterloo.ca
-
Contact:
- Allison A Legg
- Phone Number: 2893800859
- Email: a2legg@uwaterloo.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Over the age of 50 (men or post-menopausal women)
- Have had a vertebral fracture in the past two years
- Willing to participate in twelve (12) virtual rehabilitation sessions for 10 weeks
- Have access to internet and a smart device with a camera and microphone
Exclusion Criteria:
- Cauda equina syndrome or spinal cord injury
- Had a traumatic fracture (i.e., car accident)
- An active infection
- Active inflammatory arthritis with a flare up within the past two years
- An inability to follow two-step commands or understand instructions and are without a caregiver to support participation
- Been participating in a similar rehabilitation program for vertebral fractures delivered by a physical therapist, exercise physiologist or kinesiologist and includes exercise
- Any surgeries planned or health problems that might cause their health to change significantly in the next 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Immediate Receipt of VIVA
Participants receive a technology consultation 1-2 weeks prior to baseline assessment, and receive intervention in week one (immediately post-randomization). Following a virtual assessment, participants will receive twelve 1:1 virtual sessions (via Zoom) over eight weeks. |
VIVA is an intervention for people with vertebral fractures that covers four areas: pain management, safe movement, exercise, and nutrition.
It includes print and video resources, and a framework for goal setting, selecting exercises, and teaching body mechanics.
|
|
No Intervention: Control
Participants receive a technology consultation 1-2 weeks prior to baseline assessment, and receive intervention in week ten (waitlist control).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility of Chiropractic Delivery
Time Frame: We will consider ≥80% retention at 20 weeks acceptable. Adherence will be defined as ≥2 sessions per week of exercise at 20 weeks
|
This trial will be considered feasible if a) we recruit 14 people in eight months; b) 80% of participants complete the trial; and c) exercise adherence is 75%.
|
We will consider ≥80% retention at 20 weeks acceptable. Adherence will be defined as ≥2 sessions per week of exercise at 20 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant experience
Time Frame: At completion of 10 weeks.
|
We will lead exit interviews using an interview guide with open-ended questions guided by user-centred design principles.
|
At completion of 10 weeks.
|
|
Pain and Quality of Life
Time Frame: Will be measured at weeks 10/20 (effectiveness) and 20 weeks (sustainability, immediate group only
|
Using the QUALEFFO-41 to measure health-related quality of life, the QUALEFFO-41 also includes questions on pain.
|
Will be measured at weeks 10/20 (effectiveness) and 20 weeks (sustainability, immediate group only
|
|
Health-Related Quality of life
Time Frame: Will be measured at weeks 10/20 (effectiveness) and 20 weeks (sustainability, immediate group only
|
We will use the EuroQOL instrument (EQ5D5L) to measure health-related quality of life
|
Will be measured at weeks 10/20 (effectiveness) and 20 weeks (sustainability, immediate group only
|
|
Physical Performance - Balance
Time Frame: Physical performance will be measured at weeks 10/20 (effectiveness) and 20 (sustainability, immediate group only).
|
We will assess static balance via three point balance scale from the Short Physical Performance Battery. Scoring: A. Side-by-side-stand Held for 10 sec ❒ 1 point Not held for 10 sec ❒ 0 points Not attempted ❒ 0 points Number of seconds held if less than 10 sec: _______ sec *If 0 points, end Balance Tests B. Semi-Tandem Stand Held for 10 sec ❒ 1 point Not held for 10 sec ❒ 0 points Not attempted ❒ 0 points Number of seconds held if less than 10 sec: _______ sec *If 0 points, end Balance Tests C. Tandem Stand Held for 10 sec ❒ 2 points Held for 3 to 9.99 sec ❒ 1 point Held for < than 3 sec ❒ 0 points Not attempted ❒ 0 points (circle reason above) |
Physical performance will be measured at weeks 10/20 (effectiveness) and 20 (sustainability, immediate group only).
|
|
Physical Performance - Sit to Stand Performance
Time Frame: Physical performance will be measured at weeks 10/20 (effectiveness) and 20 (sustainability, immediate group only)
|
We will assess sit-to-stand performance (30 Second Chair Stand Test). Test Instructions With your shoes on, complete as many repetitions as you can safely and at your own pace. Single Chair Stand (Practice)
Scoring: 30s Chair Stand Test AGE Men Women 60-64 < 14 < 12 65-69 < 12 < 11 70-74 < 12 < 10 75-79 < 11 < 10 80-84 < 10 < 9 85-89 < 8 < 8 90-94 < 7. < 4 |
Physical performance will be measured at weeks 10/20 (effectiveness) and 20 (sustainability, immediate group only)
|
|
Adherence to diet recommendations
Time Frame: Measured at 20 weeks, immediate group only
|
Protein, calcium, vitamin D and energy intake will be measured with ASA24 and compared to Health Canada recommended dietary allowances.
|
Measured at 20 weeks, immediate group only
|
|
Adverse events
Time Frame: On-going, disclosed during intervention sessions, or at assessment milestones (week 10 and 20).
|
We will ask participants to report adverse events, defined using Health Canada definitions and established protocols. We will report all serious and non-serious adverse events (including falls, fractures) and identify them as: a) Expected/Unexpected and b) Related/unrelated to the intervention program. Participants instructed to inform chiropractor if they have an adverse event. "If you have an illness, injury, or need to get medical help, whether it is due to study participation or not, please contact us." During the week 10 and week 20 assessments, assessors to inquire about whether the participant had any illnesses or injuries. |
On-going, disclosed during intervention sessions, or at assessment milestones (week 10 and 20).
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CTO 4816
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis
-
Radius Health, Inc.CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporosis Fracture | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of Vertebrae | Osteoporosis VertebralUnited States
-
Radius Health, Inc.CompletedOsteoporosis | Age Related Osteoporosis | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of VertebraeUnited States, Poland, Italy
-
National Taiwan University HospitalNational Taiwan UniversityNot yet recruitingOsteoporosis | Postmenopausal Osteoporosis | Postmenopausal Osteopenia | Primary OsteoporosisTaiwan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States, Puerto Rico
-
National Taiwan University HospitalRecruitingOsteoporosis | Osteoporosis PostmenopausalTaiwan
-
AmgenCompletedPostmenopausal Osteoporosis (PMO)Japan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisPakistan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisBelgium, Luxembourg, Austria, Greece, Ireland
-
Hoffmann-La RocheNo longer availablePostmenopausal OsteoporosisTaiwan
Clinical Trials on VIVA
-
Venus ConceptCompleted
-
Venus ConceptCompletedWrinkle | RhytidesUnited States
-
Venus ConceptCompletedAcne Scars - Mixed Atrophic and Hypertrophic | WrinkleUnited States
-
Venus ConceptCompletedWrinkle | RhytidesUnited States
-
Venus ConceptCompletedAcne ScarsUnited States
-
University of AlbertaMitacs; Canadian Foundation for Dietetic Research (CFDR); Revive Wellness Inc.CompletedPhysical Activity | Stress | Health Behavior | NutritionCanada
-
Venus ConceptCompletedAcne Scars - Mixed Atrophic and HypertrophicUnited States
-
University of AlbertaRevive Wellness Inc.Completed
-
University of WaterlooMcGill University Health Centre/Research Institute of the McGill University... and other collaboratorsCompletedOsteoporosis | Fractures, SpinalCanada
-
Venus ConceptCompletedAcne ScarsUnited States